GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neutra Corp (OTCPK:NTRR) » Definitions » DeferredTaxAndRevenue

NTRR (Neutra) DeferredTaxAndRevenue : $0.00 Mil (As of Apr. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Neutra DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Neutra's current deferred tax and revenue for the quarter that ended in Apr. 2024 was $0.00 Mil.

Neutra DeferredTaxAndRevenue Historical Data

The historical data trend for Neutra's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra DeferredTaxAndRevenue Chart

Neutra Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Neutra Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neutra DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Neutra's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Neutra Business Description

Traded in Other Exchanges
N/A
Address
2500 CityWest Boulevard, Suite 150-161, Houston, TX, USA, 77042
Neutra Corp is a research and development company that intends to market and participate in the nutraceutical space by bringing products derived from all-natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. It sells hemp-derived products, including products containing delta-8-THC and other cannabinoids. Geographically, all the activities are operated through the region of the United States.
Executives
Sydney Jim director, officer: CEO & Chairman 8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243